Related Experiment Video
Updated: Oct 8, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
[Effects of exogenous wild type p53 on malignant growth of human lung cancer cell line]
1Cellular and Molecular Biology Lab, Beijing Thoracic Tumor Research Institute, Beijing 101149.
Objective:
To study the effects of exogenous wild type p53 suppressor gene on malignant growths of human lung cancer cell line with mutant type p53 gene.
Method:
Four human lung cancer cell line were screened for mutations in the exon 5 through exon 8 of the p53 tumor suppressor gene with immunohistochemistry, polymerase chain reaction (PCR)/single strand conformation polymorphism (SSCP) and DNA sequence analysis. The recombinent plasmid PZIPneoSV-p53 was constructed, which express wild type p53 gene. A transfected cell line, 801-D-p53, was obtained after transferred the plasmid into 801-D cell line by gene gun mediated and selected by G418. The exogenous p53 in the transfected cell line 801-D-p53 were inspected with PCR, and the alteration of growths of the transfected cell line in vitro and in vivo was observed.
Result:
The point mutation were CGG to CTT transversion at codon 248 in exon 7 was found in human lung cancer cell line 801-D by PCR-SSCP and DNA sequence analysis and nuclear accumulation of the p53 protein was observed. The neo gene and exogenous wild type p53 gene were detected in the transfected cell line 801-D-p53. The cell growth experiment in vitro showed that the parent cell line 801-D growth was very fast, from 1 x 10(5)/ml to 2.5 x 10(5)/ml within 6 days, the transfected PZIP-neo-SV cell line (plasmid without p53) growth as fast as 801-D, but the transfected cell line 801-D-p53 growth was inhibited seriously. The clonogenic formation rate of the parent cell line 801-D, transfected cell line 801-D-PZIP and the transfected cell line 801-D-p53 were 11.2%, 11.4% and 0.46% respectively. The clononogenic formation inhibition rate of the transfected 801-D-p53 was 96% comparing with the parent 801-D cell line. In the experiment of xenogenic tumor transplantation, each cell line was injected subcutaneously into four mice and the growth of xenogenic tumor transplant in nude mice was observed. xenograft growth in all 4 mice in both 801-D and 801-D-PZIP groups, but only 1 xenograft growth among 4 mice of 801-D-p53 group during 2 months. The average volume of xenogenic tumor transplant of 801-D and 801-D-PZIP groups were 6.500 cm3 and 2.231 cm3 respectively and the only xenograft volume of 801-D-p53 group was 0.940 cm3. The tumorigenicity of 801-D-p53 in nude mice was significantly suppressed.
Conclusion:
Exogenous wild type p53 gene may stably exist in the human lung cancer cell line with mutant type p53 after plasmid transfection and suppressed the malignant growth of the transfected cell line 801-D-p53 in vitro and in vivo. These results indicate that the recombinent plasmid expressing wile type p53 may be useful for gene therapy of human lung cancer.
Insights
Introducing wild type p53 suppressor gene into human lung cancer cells with mutant p53 significantly inhibited tumor growth in vitro and in vivo. This suggests gene therapy with wild type p53 may be effective for lung cancer treatment.
Area of Science:
- Molecular biology
- Cancer genetics
- Gene therapy
Context:
- The p53 tumor suppressor gene plays a critical role in preventing cancer.
- Mutations in the p53 gene are common in many human cancers, including lung cancer.
- Restoring wild type p53 function is a potential therapeutic strategy.
Purpose:
- To investigate the effects of introducing an exogenous wild type p53 gene into a human lung cancer cell line harboring a mutant p53 gene.
- To assess the impact on malignant growth both in vitro and in vivo.
Summary:
- Human lung cancer cell line 801-D with a mutant p53 gene was transfected with a plasmid expressing wild type p53.
- The transfected cell line (801-D-p53) exhibited significantly inhibited growth in vitro, with a 96% reduction in colony formation.
- In vivo studies showed suppressed tumorigenicity in nude mice, with reduced tumor incidence and volume compared to control groups.
Impact:
- Stable expression of exogenous wild type p53 suppressed malignant proliferation of lung cancer cells.
- These findings support the potential of gene therapy using wild type p53 for treating human lung cancer.
